Overview
Andrew Lassman is a Neurologist in New York, New York. Dr. Lassman is rated as an Elite provider by MediFind in the treatment of Glioblastoma. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.
His clinical research consists of co-authoring 122 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 54 articles and participated in 4 clinical trials in the study of Glioblastoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
51 W 51st St, New York, NY 10019
710 W 168th St, New York, NY 10032
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
Trustees Of Columbia University In The City Of New York
Fabio Iwamoto is a Neurologist in New York, New York. Dr. Iwamoto is rated as an Elite provider by MediFind in the treatment of Glioblastoma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.
Memorial Neurology Group
Thomas Kaley is a Neurologist in New York, New York. Dr. Kaley is rated as an Elite provider by MediFind in the treatment of Glioblastoma. His top areas of expertise are Astrocytoma, Glioblastoma, Meningioma, and Glioma.
Gerald J. Glasser Brain Tumor Center
Dr. Robert Aiken is a fellowship-trained neuro-oncologist and part of the Atlantic Medical Group Neuroscience Institute at Overlook Medical Center. With years of expertise in academic, clinical and administrative roles, and board-certified in neurology and neuro-oncology, he specializes in the diagnosis and management of patients with brain tumors, tumors of the spinal cord and nerves, as well as the management of paraneoplastic disorders involving the brain and nervous system. His particular interest involves translating new discoveries and developing new therapies for these disorders. A devoted researcher and educator, Dr. Aiken serves as co-director of the Gerald J. Glasser Brain Tumor Center at Atlantic Health System. He also served as director of neuro-oncology at Rutgers-Cancer Institute of New Jersey of Rutgers University. Previously, he held academic appointments in neurology, neurosurgery and oncology at Mount Sinai School of Medicine in NYC and Rush University Medical Center in Chicago. He combines clinical knowledge and extensive research in brain and spinal tumors. Dr. Aiken provides patients with a comprehensive evaluation and discusses their disease at length and the available treatments. After receiving his medical degree from Wayne State University School of Medicine in Detroit, MI, Dr. Aiken completed an internship and residency in internal medicine at Baylor College of Medicine in Houston, TX, then pursued neurologic training at the Neurological Institute of New York, Columbia-Presbyterian Medical Center. Post-residency, Dr. Aiken received his fellowship training at Memorial Sloan-Kettering Cancer Center. He is the author of many professional research journal articles. Dr. Aiken has been named among America’s Top Doctors and America’s Top Doctors for Cancer from Castle Connolly, Best Doctors in Philadelphia, New York and Chicago and by Inside Jersey magazine. He is on many best doctors lists. Dr. Aiken is part of Atlantic Medical Group and a participating provider of the Atlantic Accountable Care Organization. Dr. Aiken is rated as an Elite provider by MediFind in the treatment of Glioblastoma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliosarcoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AstrocytomaDr. Lassman isElite. Learn about Astrocytoma.
- Brain TumorDr. Lassman isElite. Learn about Brain Tumor.
- GlioblastomaDr. Lassman isElite. Learn about Glioblastoma.
- GliomaDr. Lassman isElite. Learn about Glioma.
- Gliomatosis CerebriDr. Lassman isElite. Learn about Gliomatosis Cerebri.
- OligodendrogliomaDr. Lassman isElite. Learn about Oligodendroglioma.
- Distinguished
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Lassman isDistinguished. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Embryonal Tumor with Multilayered RosettesDr. Lassman isDistinguished. Learn about Embryonal Tumor with Multilayered Rosettes.
- EpendymomaDr. Lassman isDistinguished. Learn about Ependymoma.
- GliosarcomaDr. Lassman isDistinguished. Learn about Gliosarcoma.
- Metastatic Brain TumorDr. Lassman isDistinguished. Learn about Metastatic Brain Tumor.
- NeuroepitheliomaDr. Lassman isDistinguished. Learn about Neuroepithelioma.
- Experienced
- Brain Stem CancerDr. Lassman isExperienced. Learn about Brain Stem Cancer.
- Dysembryoplastic Neuroepithelial Tumors (DNET)
- GangliogliomaDr. Lassman isExperienced. Learn about Ganglioglioma.
- SeizuresDr. Lassman isExperienced. Learn about Seizures.
- SubependymomaDr. Lassman isExperienced. Learn about Subependymoma.
